Improving Outcome of Human Immunodeficiency Virus-Infected Patients in a Mexican Intensive Care Unit

Archives of Medical Research

Volumn 38, Issue 8, 2007, Pages 827-833

  Vargas Infante, Yetlanezi A ^a   Guerrero, M Lourdes ^b   Ruiz Palacios, Guillermo M ^a   Soto Ramírez, Luis E ^a   Del Río, Carlos ^c   Carranza, Jorge ^a   Domínguez Cherit, Guillermo ^a   Sierra Madero, Juan G ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Critical care; HIV; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; SERUM ALBUMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; OUTCOME ASSESSMENT; SCORING SYSTEM; SEPTIC SHOCK; SURVIVAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APACHE; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MEXICO; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34848917366     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.05.007     Document Type: Article

References (52)

1. Schein R.M., Fischl M.A., Pitchenik A.E., and Sprung C.L. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 14 (1986) 1026-1027
2. Lazard T., Retel O., Guidet B., Maury E., Valleron A.J., and Offenstadt G. AIDS in a medical intensive care unit: immediate prognosis and long-term survival. JAMA 276 (1996) 1240-1245
3. Choperena G., Arcega I., Marco P., Alberdi F., Azaldegui F., Alberola I., et al. Supervivencia al año de los pacientes VIH positivos ingresados en UCI en el período previo a la terapia antirretroviral combinada. Med Intensiva 24 (2000) 392-397
4. Casalino E., Wolff M., Ravaud P., Choquet C., Bruneel F., and Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 18 (2004) 1429-1433
5. Morris A., Creasman J., Turner J., Luce J.M., Wachter R.M., and Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 166 (2002) 262-267
6. Masur H. Acquired immunodeficiency syndrome in the intensive care unit. Will human immunodeficiency virus-related admissions continue to decline?. Am J Respir Crit Care Med 166 (2002) 258-259
7. Arozullah A.M., Yarnold P.R., Weinstein R.A., Nwadiaro N., McIlraith T.B., Chmiel J.S., et al. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med 161 (2000) 1081-1086
8. Narasimhan M., Posner A.J., DePalo V.A., Mayo P.H., and Rosen M.J. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 125 (2004) 1800-1804
9. Gagnon S., Boota A.M., Fischi M.A., Baier H., Kieksey O.W., and La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323 (1990) 1444-1450
10. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323 (1990) 1500-1504
11. Mansharamani N.G., Garland R., Delaney D., and Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 118 (2000) 704-711
12. Wachter R.M., Luce J.M., Turner J., Volberding P., and Hopewell P. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis 134 (1986) 891-896
13. Brown J., and Sprung C.L. Ethical considerations in the treatment of AIDS in the intensive care unit. Crit Care Clin 9 (1993) 115-123
14. Silverman H.J. How decisive are physician values in the end-of-life decision-making?. Crit Care Med 24 (1996) 909-911
15. Curtis J.R., Greenberg D.L., Hudson L.D., Fisher L.D., Krone M.R., and Collier A.C. Changing use of intensive care for HIV-infected patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 150 (1994) 1305-1310
16. Nicoll A., and Killewo J. Science, sense and nonsense about HIV in Africa. Commun Dis Public Health 3 (2000) 78-79
17. Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO AIDS Epidemic Update: December 2005. UNAIDS [Reports on line] 2005 Dec [cited 2006 Mar 09]. Available from: http://www.unaids.org/epi/2005/doc/EPIupdate2005_pdf_sp/epi-update2005_sp.pdf.
18. Timsit J.F. Open the intensive care unit doors to HIV-infected patients with sepsis. Crit Care 9 (2005) 629-630
19. Wachter R.M., Russi M.B., Bloch D.A., Hopewell P.C., and Luce J.M. Pneumocystis carinii pneumonia and respiratory failure in AIDS: improved outcomes and increased use of intensive care units. Am Rev Respir Dis 143 (1991) 251-256
20. Levy R.M., and Berger J.R. Neurologic critical care in patients with human immunodeficiency virus 1 infection. Crit Care Clin 9 (1993) 49-67
21. Nickas G., and Wachter R.M. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 160 (2000) 541-547
22. Casalino E., Mendoza-Sassi G., Wolff M., Bedos J.P., Gaudebout C., Regnier B., et al. Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 113 (1998) 421-429
23. Rosen M.J., Clayton K., Schneider R.F., Fulkerson W., Rao A.V., Stansell J., et al. Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes: pulmonary complications of HIV Infection Study Group. Am J Respir Crit Care Med 155 (1997) 67-71
24. Curtis R.J., Yarnold P.R., Schwartz D.N., Weinstein R.A., and Bennett C.L. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 162 (2000) 393-398
25. Benfield T.L., Helweg-Larsen J., Bang D., Junge J., and Lundgren J.D. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest 119 (2001) 844-851
26. Wachter R.M., Luce J.M., Safrin S., Berrios D.C., Charlebois E., and Scitovsky A.A. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. JAMA 273 (1995) 230-235
27. Afessa B., and Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU: The PIP (pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) Study. Chest 118 (2000) 138-145
28. Chu D.Y. Predicting survival in AIDS patients with respiratory failure. Crit Care Clin 9 (1993) 89-105
29. Rosen M.J., and De Palo V.A. Outcome of intensive care for patients with AIDS. Crit Care Clin 9 (1993) 107-114
30. Forrest D.M., Zala C., Djurdjev O., Singer J., Craib K.J., Lawson L., et al. Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia. Arch Intern Med 159 (1999) 741-747
31. Benson C., Spear J., Hines D., Kessler H., and Trenholme G. Combined APACHE II and serum lactate dehydrogenase as predictors of in-hospital mortality caused by first episode Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 144 (1991) 319-323
32. Bozzette S.A., Sattler F.R., Chiu J., Wu A.W., Gluckstein D., Kemper C., et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystitis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 22 (1990) 1451-1455
33. Kumar S.D., and Krieger B.P. CD4 lymphocyte counts and mortality in AIDS patients requiring mechanical ventilator support due to Pneumocystis carinii pneumonia. Chest 113 (1998) 430-433
34. Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services (DHHS). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. AIDSinfo [Guidelines on line] 2005 Oct [cited 2006 March 08]. Available from: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
35. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., and Knaus W.A. ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992) 1644-1655
36. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR [serial on line]1992 Dec [cited 2006 March 08]; 41(RR-17). Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm.
37. American Thoracic Society 1993. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148 (1993) 1418-1426
38. Ewig S., Torres A., Arancibia F., Mensa J., Martinez J.M., and Gonzalez J. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 158 (1998) 1102-1108
39. Leifeld L., Rockstroh J., Skaide S., Wasmuth J.C., Altfeld M., Paar W.D., et al. Indication, outcome and follow up of intensive care in patients with HIV-infection. Eur J Med Res 5 (2000) 199-202
40. Cowan M.J., Shelhamer J.H., and Levine S.J. Acute respiratory failure in the HIV-seropositive patient. Crit Care Clin 13 (1997) 523-551
41. Alves C., Nicolas J.M., Miro J.M., Torres A., Agusti C., Gonzalez J., et al. Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J 17 (2001) 87-93
42. Rosel-Ramírez R., Loria A., Domínguez-Cherit G., and Gutiérrez-Sougarret B. Un modelo predictivo de mortalidad en una ICU de un hospital de la ciudad de México. Rev Invest Clin 56 (2004) 591-599
43. Bhagwanjee S., Muckart D.J.J., Jeena P.M., and Moodley P. Does HIV status influence the outcome of patients admitted to a surgical intensive care unit? A prospective double blind study. BMJ 314 (1997) 1077-1081
44. Casalino E., Wolff M., Mendoza-Sassi G., Bedos J.P., Lucet J.C., and Vachon F. Prognostic factors and outcome of intensive care for HIV infected patients. Int Conf AIDS 9 (1993 Jun 6-11) 62 (abstract no. WS-B19-2)
45. Le Gall J.R., Lemeshow S., and Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270 (1993) 2957-2963
46. Brooks K.R., Ong R., Spector R.S., and Greenbaum D.M. Acute respiratory failure due to Pneumocystis carinii pneumonia. Crit Care Clin 9 (1993) 31-48
47. Marik P.E., Kiminyo K., and Zaloga G.P. Adrenal insufficiency in critically ill patients with immunodeficiency virus. Crit Care Med 30 (2002) 1267-1273
48. Meduri G.U., Headley A.S., Golden E., Carson S.J., Umberger R.A., Kelso T., et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280 (1998) 159-165
49. Murphy E.L., Collier A.C., Kalish L.A., Assmann S.F., Para M.F., Flanigan T.P., et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 135 (2001) 17-26
50. Valdez H., Chowdhry T.K., Asaad R., Woolley I.J., Davis T., Davidson R., et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 32 (2001) 1487-1493
51. Palella F., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., and the HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
52. Morris A. Intensive care of patients with HIV infection. Chest 125 (2004) 1602-1603